PUBLISHER: The Insight Partners | PRODUCT CODE: 2165967
PUBLISHER: The Insight Partners | PRODUCT CODE: 2165967
The North America Automated Peritoneal Dialysis Market is projected to grow from US$ 377.1 Million in 2025 to US$ 539.8 Million by 2034. The market is anticipated to register a CAGR of 4.1% during the forecast period from 2026 to 2034.
Executive Summary and North America Automated Peritoneal Dialysis Market Analysis
The North America automated peritoneal dialysis market is witnessing steady growth, supported by the increasing prevalence of kidney disease, growing acceptance of home-based dialysis therapies, and favorable healthcare policies. According to the Centers for Medicare & Medicaid Services Kidney Care Choices Model report (2025), home dialysis represents nearly 14% of all dialysis treatments in the United States, while peritoneal dialysis accounts for approximately 12%. This development reflects a broader regional movement toward home-based treatment models designed to reduce pressure on healthcare infrastructure while improving patient convenience and quality of life.
In Canada, data from the Canadian Institute for Health Information 2024 CORR report indicates that more than 50,000 people were living with end-stage kidney disease (ESKD), highlighting a substantial population requiring effective and accessible dialysis options. Across North America, adoption of automated peritoneal dialysis is also benefiting from technological progress in cycler systems. Modern APD devices facilitate overnight dialysis sessions and incorporate remote monitoring capabilities, helping improve treatment adherence, convenience, and clinical management.
Furthermore, the United States Renal Data System continues to provide dialysis modality data through quarterly updates extending into 2025. The continued monitoring of home dialysis trends demonstrates sustained demand for alternative renal replacement therapies and supports the ongoing expansion of APD across the North American healthcare market.
Strategic Insights
North America Automated Peritoneal Dialysis Market Segmentation Analysis
By Product Type, the North America Automated Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution, Peritoneal Dialysis Catheters, Peritoneal Dialysis Transfer Sets, and Others. The Peritoneal Dialysis Solution segment held the largest market share in 2025.
By End User, the North America Automated Peritoneal Dialysis Market is categorized into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings segment dominated the market in 2025.
Market Report Scope
North America Automated Peritoneal Dialysis Market Outlook
According to the 2025 United States Renal Data System (USRDS) Annual Data Report, utilization of home dialysis, including peritoneal dialysis modalities, reached approximately 15% among new and prevalent ESRD patients in 2023. Worldwide, healthcare providers and policymakers are increasingly moving toward patient-centered treatment models that enable individuals to receive care at home, thereby reducing the frequency of visits to dialysis centers and potentially enhancing quality of life.
Although the reported figure incorporates both peritoneal dialysis and home hemodialysis, clinical trends indicate that automated peritoneal dialysis is frequently selected as the preferred PD approach among home dialysis patients in developed healthcare systems. In the United States, APD represents the majority of peritoneal dialysis prescriptions, reflecting strong acceptance of automated treatment among eligible patients.
The increasing global prevalence of chronic kidney disease, driven by factors such as population aging, diabetes, and hypertension, is generating greater demand for adaptable renal replacement therapies. The transition toward home-based treatment demonstrates increasing patient and provider confidence in home dialysis modalities while supporting healthcare policies focused on patient independence and more efficient use of medical resources. These factors are collectively contributing to the growing adoption of APD in North America and other developed healthcare markets.
North America Automated Peritoneal Dialysis Market Country Insights
By country, the North America Automated Peritoneal Dialysis Market is divided into the United States, Canada, and Mexico. The United States accounted for the largest market share in 2025.
The US Automated Peritoneal Dialysis Market is expanding as home dialysis adoption increases alongside supportive government policies and advances in medical technology. According to the Centers for Medicare & Medicaid Services Kidney Care Choices Model report (2025), home peritoneal dialysis accounts for approximately 12% of all dialysis treatments in the country, while total home dialysis represents nearly 14%. These figures demonstrate the continuing transition toward home-based dialysis and the growing role of alternatives to conventional in-center hemodialysis.
According to the United States Renal Data System, ESRD reporting continues through 2025 through its Quarterly Update system, enabling ongoing monitoring of peritoneal dialysis patient numbers and treatment modality utilization. Government initiatives have also supported the expansion of home dialysis through reimbursement mechanisms and care model reforms that encourage patient education, training, and adoption of home-based dialysis.
Technological developments are further improving the feasibility of APD for a wider patient population. Newer automated cyclers provide automated fluid exchanges and increasingly incorporate remote monitoring capabilities, enhancing treatment convenience, safety, and clinical oversight. Combined with the country's substantial dialysis patient population and growing emphasis on patient-centered healthcare delivery, these factors are accelerating the adoption of automated peritoneal dialysis across the United States.
North America Automated Peritoneal Dialysis Market Company Profiles
Major companies operating in the North America Automated Peritoneal Dialysis Market include Terumo Corp, Medtronic Plc, Asahi Kasei Corp, Baxter International Inc, Fresenius Medical Care AG & Co KGaA, B. Braun SE, Angiplast, Becton Dickinson and Co, Utah Medical Products Inc, and Poly Medicure Ltd.
These companies are pursuing various strategies, including geographical expansion, product innovation, strategic partnerships, and mergers and acquisitions. Such initiatives are intended to strengthen product portfolios, introduce advanced dialysis solutions, address evolving patient and healthcare-provider needs, and expand their presence and market share in the automated peritoneal dialysis industry.